Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7305 p802
26 June 2004

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader

Letters

· The Society
· Pharmacy education
· Patient safety
· Statins
· Dispensing
· Packaging
· Resources


Letters to the Editor

Pharmacy education

MPharm courses should concentrate on pharmacy practice

From Mr D. S. D. McRobbie, MRPharmS

I obviously struck a nerve for daring to suggest that UK pharmacy undergraduate programmes fail to prepare future pharmacists for practice (PJ, 29 May, p671).

I think I should substantiate my argument and defend my comments made at the International Congress on Clinical Pharmacy in Paris (PJ, 8 May, p582). Pharmacists in French hospitals have significantly different roles and responsibilities. These include responsibility for the central sterile supply department and biochemical laboratory results — not something usually found in the job descriptions of UK hospital pharmacists. As these are important roles in this context, the alleged decrease of “science” and the increase of “clinical” were obviously concerns for them. I would argue this is not so for UK pharmacists.

The vast majority of UK pharmacy graduates will go on to deliver some form of direct patient care, at least in the early stages of their career. Let us for the sake of argument call this “clinical” work. The dictionary definition of “clinical” is “pertaining to the bedside” (from the Greek — klinicos). Also “pertaining to or founded on actual observation and treatment of patients as distinguished from theoretical or basic sciences”.

Last year’s census shows 94 per cent of registered working pharmacists are in either community or hospital pharmacy.1 This clinical work occurs in both these areas on a regular basis. Pharmacists’ skills are sought for the management of minor ailments, to educate patients on their medicines and to ensure the appropriateness of medicines. I would suggest that they are rarely, if ever, asked for advice on “synthesis or isolation of drugs, their physical and chemical properties, or methods of analysis” (taken from the programme outline, School of Pharmacy webpage, www.ulsop.ac.uk, accessed June 2004).

We presented data at the 2002 British Pharmaceutical Conference identifying the tasks that we thought pharmacists leaving university should be able to perform in order to ensure patient safety.2 These data demonstrated that at the beginning of their preregistration year less than a third could undertake simple patient counselling, provide routine health promotion or basic therapeutic drug monitoring. Less than a quarter could take a drug history and only 11 per cent could do simple dose conversions.

Unlike many of our health care colleagues, let us take doctors and nurses as an example, pharmacy undergraduates have limited (if any) exposure to patients. Educational experts will tell us that learning best occurs when the subject matter is placed in context. The cynic in me believes that denying pharmacy undergraduates exposure to the real jobs they may be doing (and patients they will be treating) allows the “scientists” to perpetuate the myth of the importance of their science to the profession. What most graduates realise in their early days of practice is that this is not so.

One solution may be for schools of pharmacy to focus on those skills most important for the majority of practising pharmacists, leaving the specialist science, which is no doubt important to colleagues in technical and industrial areas, to be learned as and when the need for this knowledge arises. After all it was Hippocrates who said, “A clinician’s role is to cure rarely, comfort mostly but to console always.”

However, I share A. T. (Sandy) Florence’s concerns regarding the uncontrolled increase in the number of schools of pharmacy (and undergraduate numbers). The resources required to produce graduates are no doubt considerable. The effort required during the preregistration year to make them safe practitioners is also considerable. Due in some degree to the educational effort required, the number of preregistration places is not increasing at the same pace as the number of graduates. Concerns regarding their ability to gain a preregistration place will surely have knock on effects on the number of school leavers choosing pharmacy as an option.

Duncan McRobbie
Principal Clinical Pharmacist
Guy’s and St Thomas’ Hospital Trust

References

1. Hassell K, Shann P. Pharmacy workforce census: overview of main census findings The Pharmaceutical Journal 2003:270;314–5.
2. McRobbie D, Fleming G, Ortner M, Bates I, Davies JG. Measuring clinical competence in preregistration trainees using OSCEs. International Journal of Pharmacy Practice 2002:10(suppl):R7 (PDF 60K)

Send your letter to The Editor

Previous Topic (The Society)
Next Topic (Patient safety)

Back to Top


©The Pharmaceutical Journal